Vascular Stents Market Research Report - Forecast till 2027

Vascular Stents Market Research Report: Information by Type [Coronary Stents, Peripheral Stents (Carotid Artery Stents, Renal Artery Stents, Femoral Artery Stents, Iliac Artery Stents and others) and Evar Stent Grafts (Abdominal Aortic Aneurysm Stents and Thoracic Aortic Aneurysm Stents)], Material [Metallic Stents (Platinum Chromium, Cobalt-Chromium, Nickel-Titanium and Stainless Steel), Ceramics Stents and Polymers Stents], End User (Hospitals, Cardiac Centers, and Ambulatory Surgical Centers) and Region (Americas, Europe, Asia-Pacific and Middle East Africa) - Forecast till 2027

ID: MRFR/MED/0899-HCR | February 2021 | Region: Global | 95 pages

Vascular Stents Market Overview


Vascular Stents Market is expected to register 7.7% CAGR during the forecast period of 2019 to 2025, with a market value of USD 16788.9 Million in 2018.


Vascular Stents are tiny tubular scaffolds that are widely used to treat arterial stenosis and prevent vessels' acute closure. Such rigid devices are based on the shape memory effect (SME), and they support tubular structures and help them hold them in position. The application of vascular stents has gained considerable popularity as it enables vascular surgeons to use a hollow mesh tube to support the walls of blood vessels and prevent blockage. The vascular stents market is a promising market that has revolutionized the healthcare industry, especially the cardiovascular domain. 


The vascular stents market is expected to showcase solid performance during the forecasted period. Based on the comprehensive vascular stents industry forecast, the market is expected to register 7.7 CAGR during the projected period. One of the main factors that could lead to market growth is the rise in incidents of vascular diseases. According to the World Health Organization (WHO), approximately 17.9 million people lose their lives annually due to varying cardiovascular diseases. 


A detailed vascular stents market analysis has been conducted that captures its growth potential during the forecasted period. Various factors that come into play and shape the vascular stents' market size have been identified in the report, such as market drivers, constraints, opportunities, and restraints. The detailed insight into the prevailing vascular stents industry trends has helped to predict the performance of the market in the future. 


Covid 19 analysis


In the 21st century, the Covid 19 pandemic has acted as a major factor that has redefined the vascular stents market landscape at the global level. Due to stringent regulations and norms relating to social distancing, people suffering from vascular complexities have not been able to get suitable treatment for vascular health conditions. It has adversely affected the overall demand for vascular stents in the vast market. However, the pandemic has also created diverse opportunities for business entities. For instance, businesses have been integrating new types of digital technologies in the business processes to deliver improved quality of care and treatment. 


Major market variables 



  • Market drivers


The rise in the incidence of vascular conditions among people all across the globe has increased the demand in the vascular stents market. People have been opting for minimally invasive medical procedures instead of undergoing serious and complex surgeries. Another factor that acts as a major market driver is the rapid innovation in stenting technologies. These elements could contribute to the rise in the global vascular stents market value during the forecasted period.



  • Market challenges


A number of challenges exist in the global vascular stents market landscape and increase the complexity for business players that function in it. One of the major challenges revolves around the regulatory requirements. Businesses need to adhere to the latest laws and legislation while working on their innovative vascular stenting solutions. Another challenge that exists in the global market setting is the intense competition. Based on the forecast, most market players have been working on their strategic approaches to capture a considerable portion of the global vascular stents industry share.



  • Opportunities in the global market


Several opportunities exist in the global vascular stents market, such as adopting innovative technologies to strengthen the effectiveness and safety of the treatment procedure. The industry's attractiveness is considered high as people have been inclined towards minimally invasive vascular surgeries. Several industry players have been integrating new digital technologies to capitalize on favorable market conditions. The existence of diverse opportunities during the forecasted period could influence its vascular stents industry value.



  • Restraints


A major restraint in the global vascular stents market relates to the high instances of product failure. Similarly, there are also many instances of product recalls which affect the growth of the market. Based on the detailed evaluation of the vascular stents industry, these elements could adversely affect the performance of the market in the future. 



  • Cumulative evaluation of the market


The comprehensive vascular stents market outlook report has captured a diverse range of variables in the global market setting. Some of the chief factors that have been identified include the rise in vascular health complexities in individuals at the global level and the integration of new technologies in the vascular stenting landscape. These are the major components that are likely to impact the performance of the market during the forecasted period. 


Overview of the main market segments



  • By Type


The global vascular stents market can be categorized into coronary stents, peripheral stents, and evar stent grafts based on type. During the forecasted period, the coronary stents segment will likely dominate the global market landscape and influence the overall size of vascular stents. The main factors that could lead to its slid performance include the high incidence of coronary artery disease and rapid advancement in coronary stents.



  • By Material


Based on the material, the global vascular stents market can be fragmented into metallic stents, cobalt-chromium, platinum chromium, nickel-titanium, stainless steel, polymers stents, and ceramics stents. The polymers stents segment has been dominating the global market due to the rise in the application of bioabsorbable sterns. It is likely to dominate the global market setting during the forecasted period as well. 



  • By End-User


Based on end-users, the global vascular stents market can be categorized into hospitals, cardiac centers, and ambulatory surgical centers. The hospital is the major end-user segment that has been shaping the performance of the global vascular stents industry landscape. The main reasons for the exceptional performance of the specific end-user segment include the high availability of angioplasty procedures and the increased expertise in healthcare settings. The hospital segment is likely to dominate the global market setting and contribute to its performance during the forecasted period.   


Regional analysis


The global vascular stents market can be divided into regions, including the Americas, Europe, Asia Pacific, the Middle East, and Africa. A diverse range of factors influences the performance of these regional market segments, such as the prevalence of vascular diseases and the availability of a robust technological infrastructure. During the forecasted period, the Americas could capture most of the vascular stents industry share due to the high prevalence of health-related disorders and the rapid adoption of digital technologies. The increasing preference for non-invasive or minimally invasive procedures could further boost the vascular stents industry growth. A diverse range of factors could come into play and influence the degree of market growth in respective regions. However, a major driving factor in most of the geographical segments includes the rising incidence of vascular health conditions in people.   


Competitive intensity in the industry


The competitive intensity in the global vascular stents market is very high due to numerous business players. Some of the top companies that have been intensifying the competition in the global business landscape are as follows: 



  • Abbott Laboratories

  • Boston Scientific Corporation

  • Medtronic Plc.

  • Terumo Corporation

  • Microport Scientific Corporation

  • Vascular Concepts

  • C. R. Bard

  • Merril Life Sciences

  • Biotronic SE & Co. KG

  • Cordis Corporation

  • Cook Medical


To sustainably function in the competitive global market, business firms have been integrating new digital technologies to facilitate vascular stents innovations. Based on the critical vascular stents market analysis, the strategic approach of the businesses could influence the market performance during the forecasted period.  


Recent market developments



  • Companies functioning in the global vascular stents industry landscape have adopted new technologies such as Artificial Intelligence to boost individuals suffering from diverse vascular health complexities.

  • Merril Life Sciences has delivered world-class cardiovascular health solutions by integrating path-breaking innovative elements, such as robotic technology.   


Report Overview


The vascular stents market outlook report has given a critical insight into the market and the varying factors that exist in it. The increase in the prevalence of vascular diseases acts as the catalyst and influences the market performance. According to the specific vascular stents industry forecast, the high disease prevalence could contribute to the market's growth. One of the top vascular stents market trends that have been captured in the report involves the rapid adoption of technology. A major bottleneck that has been adversely affecting the vascular stents industry performance is the rise in product failure.  


Key Industrial segments


By Type



  • Coronary Stents

  • Peripheral Stents

  • EvarStent Grafts


By Material



  • Metallic Stents

  • Cobalt-Chromium

  • Platinum Chromium

  • Nickel Titanium

  • Stainless Steel

  • Polymers Stents

  • Ceramics Stents


By End-User



  • Hospitals

  • Cardiac Centers

  • Ambulatory Surgical Centers



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 16788.9 Million (2018)
  CAGR   7.7% (2019-2025)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Information by Type, Evar Stent Grafts, Material
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Abbott Laboratories (US), B. Braun Melsungen Ag (Germany), Medtronic Plc (Ireland), Boston Scientific Corporation (US), Terumo Corporation (Japan), Biotronik Se & Co. Kg (Germany), Microport Scientific Corporation (China), Cook Medical (US), Vascular Concepts (India), Stentys S.A. (France), C. R. Bard (US), Meril Life Sciences (India), Cordis Corporation (US), and W. L. Gore & Associates (US).
  Key Market Opportunities   Increasing preference for minimally invasive surgeries coupled with rapid growth in the geriatric population is anticipated to fuel the market growth.
  Key Market Drivers   Product recalls and failures are projected to hamper the growth of the market during the assessment period.


Frequently Asked Questions (FAQ) :


The valuation of the vascular stents market had reached USD 16788.9 MN in 2018.

The vascular stents market is projected to grow at 7.7% CAGR during the assessment period (2019-2025).

Growing prevalence of vascular diseases and technological advances in the stents are the major tailwinds pushing the growth of the vascular stents market.

North America holds the largest share in the vascular stents market, followed by Europe and the Asia Pacific, respectively.

Abbott Laboratories (US), Boston Scientific Corporation (US), Medtronic, Plc (UK), Biotronik se & co. kg (Germany), Cook Medical (US), B. Braun Melsungen AG (Germany), Lombard Medical Technologies (UK), Cordis (US), Translumina GmbH (Germany), Terumo Corporation (Japan), MicroPort Scientific Corporation (China), Vascular Concepts (India), Meril Life Sciences Pvt. Ltd. (India), and W.L. Gore & Associates (US), are some of the major players operating in the vascular stents market.

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis


6. GLOBAL VASCULAR STENTS MARKET, BY TYPE

6.1. Overview

6.2. Coronary Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.1. Carotid Artery Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.2. Renal Artery Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.3. Femoral Artery Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.4. Iliac Artery Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.5. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. Peripheral Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4. Evar Stent Grafts

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4.1. Abdominal Aortic Aneurysm Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4.2. Thoracic Aortic Aneurysm Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7. GLOBAL VASCULAR STENTS MARKET, BY MATERIAL

7.1. Overview

7.2. Metallic Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.1. Platinum Chromium

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.2. Cobalt-Chromium

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.3. Nickel Titanium

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.4. Stainless Steel

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. Ceramics Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4. Polymers Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8. GLOBAL VASCULAR STENTS MARKET, BY END USER

8.1. Overview

8.2. Hospitals

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3. Cardiac Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4. Ambulatory Surgical Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9. GLOBAL VASCULAR STENTS MARKET, BY REGION

9.1. Overview

9.2. Americas

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. Latin America

9.3. Europe

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. Italy

9.3.1.4. Spain

9.3.1.5. UK

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa

9.5.1. Middle East

9.5.2. Africa

10. COMPANY LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Vascular Stents Market

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global Vascular Stents Market

10.7. Key developments and Growth Strategies

10.7.1. Product Launch/Service Deployment

10.7.2. Mergers and Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix & Market Ratio

10.8.1. Sales & Operating Income 2020

10.8.2. Major Players R&D Expenditure 2020

10.9. Major Players Capital Market Ratio

11. COMPANY PROFILES

11.1. Abbott Laboratories

11.1.1. Company Overview

11.1.2. Product Overview

11.1.3. Financial Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. B. Braun Melsungen Ag

11.2.1. Company Overview

11.2.2. Product Overview

11.2.3. Financial Overview

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Medtronic Plc

11.3.1. Company Overview

11.3.2. Product Overview

11.3.3. Financial Overview

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Boston Scientific Corporation

11.4.1. Company Overview

11.4.2. Product Overview

11.4.3. Financial Overview

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Terumo Corporation

11.5.1. Company Overview

11.5.2. Product Overview

11.5.3. Financial Overview

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Biotronik Se & Co. Kg

11.6.1. Company Overview

11.6.2. Product Overview

11.6.3. Financial Overview

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Microport Scientifc Corporation

11.7.1. Company Overview

11.7.2. Product Overview

11.7.3. Financial Overview

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Cook Medical

11.8.1. Company Overview

11.8.2. Product Overview

11.8.3. Financial Overview

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Vascular Concepts

11.9.1. Company Overview

11.9.2. Product Overview

11.9.3. Financial Overview

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Stentys S.A.

11.10.1. Company Overview

11.10.2. Product Overview

11.10.3. Financial Overview

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

11.11. C. R. Bard

11.12. Meril Life Sciences

11.13. Cordis Corporation

11.14. W. L. Gore & Associates

11.15. Others

12. APPENDIX

12.1. References

12.2. Related Reports


LIST OF TABLES

TABLE 1 GLOBAL VASCULAR STENTS MARKET SYNOPSIS, 2020-2027

TABLE 2 GLOBAL VASCULAR STENTS MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)

TABLE 3 GLOBAL VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 4 GLOBAL VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)

TABLE 5 GLOBAL VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)

TABLE 6 GLOBAL VASCULAR STENTS MARKET, BY REGION, 2020-2027 (USD MILLION)

TABLE 7 NORTH AMERICA: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 8 NORTH AMERICA: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)

TABLE 9 NORTH AMERICA: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)

TABLE 10 US: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 11 US: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)

TABLE 12 US: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)

TABLE 13 CANADA: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 14 CANADA: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)

TABLE 15 CANADA: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)

TABLE 16 LATIN AMERICA: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 17 LATIN AMERICA: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)

TABLE 18 LATIN AMERICA: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)

TABLE 19 EUROPE: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 20 EUROPE: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)

TABLE 21 EUROPE: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)

TABLE 22 WESTERN EUROPE: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 23 WESTERN EUROPE: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)

TABLE 24 WESTERN EUROPE: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)

TABLE 25 EASTERN EUROPE: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 26 EASTERN EUROPE: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)

TABLE 27 EASTERN EUROPE: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)

TABLE 28 ASIA-PACIFIC: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 29 ASIA-PACIFIC: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)

TABLE 30 ASIA-PACIFIC: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)


LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE OF THE GLOBAL VASCULAR STENTS MARKET

FIGURE 3 MARKET DYNAMICS OF THE GLOBAL VASCULAR STENTS MARKET

FIGURE 4 GLOBAL VASCULAR STENTS MARKET SHARE, BY TYPE, 2020 (%)

FIGURE 5 GLOBAL VASCULAR STENTS MARKET SHARE, BY MATERIAL, 2020 (%)

FIGURE 6 GLOBAL VASCULAR STENTS MARKET SHARE, BY END USE, 2020 (%)

FIGURE 7 GLOBAL VASCULAR STENTS MARKET SHARE, BY REGION, 2020 (%)

FIGURE 8 AMERICAS: VASCULAR STENTS MARKET SHARE BY REGION, 2020 (%)

FIGURE 9 NORTH AMERICA: VASCULAR STENTS MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 10 EUROPE: VASCULAR STENTS MARKET SHARE, BY REGION, 2020 (%)

FIGURE 11 WESTERN EUROPE: VASCULAR STENTS MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 ASIA-PACIFIC: VASCULAR STENTS MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 13 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 14 GLOBAL VASCULAR STENTS MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 15 ABBOTT LABORATORIES.: KEY FINANCIALS

FIGURE 16 ABBOTT LABORATORIES: SEGMENTAL REVENUE

FIGURE 17 ABBOTT LABORATORIES: REGIONAL REVENUE

FIGURE 18 B. BRAUN MELSUNGEN AG: KEY FINANCIALS

FIGURE 19 B. BRAUN MELSUNGEN AG: SEGMENTAL REVENUE

FIGURE 20 B. BRAUN MELSUNGEN AG: REGIONAL REVENUE

FIGURE 21 MEDTRONIC PLC: KEY FINANCIALS

FIGURE 22 MEDTRONIC PLC: SEGMENTAL REVENUE

FIGURE 23 MEDTRONIC PLC: REGIONAL REVENUE

FIGURE 24 BOSTON SCIENTIFIC CORPORATION: KEY FINANCIALS

FIGURE 25 BOSTON SCIENTIFIC CORPORATION: SEGMENTAL REVENUE

FIGURE 26 BOSTON SCIENTIFIC CORPORATION: REGIONAL REVENUE

FIGURE 27 TERUMO CORPORATION: KEY FINANCIALS

FIGURE 28 TERUMO CORPORATION: SEGMENTAL REVENUE

FIGURE 29 TERUMO CORPORATION: REGIONAL REVENUE

FIGURE 30 BIOTRONIK SE & CO. KG: KEY FINANCIALS

FIGURE 31 BIOTRONIK SE & CO. KG: SEGMENTAL REVENUE

FIGURE 32 BIOTRONIK SE & CO. KG: REGIONAL REVENUE

FIGURE 33 MICROPORT SCIENTIFC CORPORATION: KEY FINANCIALS

FIGURE 34 MICROPORT SCIENTIFC CORPORATION: SEGMENTAL REVENUE

FIGURE 35 MICROPORT SCIENTIFC CORPORATION: REGIONAL REVENUE

FIGURE 36 COOK MEDICAL: KEY FINANCIALS

FIGURE 37 COOK MEDICAL: SEGMENTAL REVENUE

FIGURE 38 COOK MEDICAL: REGIONAL REVENUE

FIGURE 39 VASCULAR CONCEPTS: KEY FINANCIALS

FIGURE 40 VASCULAR CONCEPTS: SEGMENTAL REVENUE

FIGURE 41 VASCULAR CONCEPTS: REGIONAL REVENUE

FIGURE 42 STENTYS S.A.: KEY FINANCIALS

FIGURE 43 STENTYS S.A.: SEGMENTAL REVENUE

FIGURE 44 STENTYS S.A.: REGIONAL REVENUE

FIGURE 45 C. R. BARD: KEY FINANCIALS

FIGURE 46 C. R. BARD: SEGMENTAL REVENUE

FIGURE 47 C. R. BARD: REGIONAL REVENUE

FIGURE 48 MERIL LIFE SCIENCES: KEY FINANCIALS

FIGURE 49 MERIL LIFE SCIENCES: SEGMENTAL REVENUE

FIGURE 50 MERIL LIFE SCIENCES: REGIONAL REVENUE

FIGURE 51 CORDIS CORPORATION: KEY FINANCIALS

FIGURE 52 CORDIS CORPORATION: SEGMENTAL REVENUE

FIGURE 53 CORDIS CORPORATION: REGIONAL REVENUE

FIGURE 54 W. L. GORE & ASSOCIATES: KEY FINANCIALS

FIGURE 55 W. L. GORE & ASSOCIATES: SEGMENTAL REVENUE

FIGURE 56 W. L. GORE & ASSOCIATES: REGIONAL REVENUE